Brittni Frederiksen, the associate director for Women’s Health Policy at the nonpartisan health care think tank KFF, is among those skeptical of the groups’ findings. She highlighted, for instance, that the report lists ectopic pregnancies — when an embryo implants outside the uterus — as an “adverse event” from the pills when the pills do not cause ectopic pregnancies. Rather, according to the FDA, ectopic pregnancies are a contraindication, meaning patients are told not to take the pills in that instance because they will not work. Also, a large percentage of the harms listed in the EPPC report are patients who needed a follow-up surgical abortion because the pills did not end their pregnancies — which she and other experts argue is a known potential outcome disclosed on the medication’s label and not an “adverse event.”
Read more at Politico